July 18, 2014 by Arezu Sarvestani
Vermont medical imaging services provider DICOM Grid today announced that it raised $6 million in an inside funding round, with investment coming from Canaan Partners, CHL Medical Partners, the Mayo Clinic and several individual investors.
DICOM provides a cloud-based platform that other healthcare organizations use to manage and exchange medical images reliably and securely. The company plans to the new funds to meet growing demand for digital medical imaging services by boosting product development and seeking integration opportunities with electronic medical record providers. Read more
July 22, 2014 by Brad Perriello
A $7 million funding round for Cardiac, 1st reported by MassDevice.com, was led by Welch Allyn and includes a collaboration deal, Cardiac Insight said yesterday.
The round including contributions from WRF Capital and “other private investors,” according to a press release. Cardiac Insight said it plans to use the financing to continue developing its body-worn sensing and computing technologies, expand its research program and “accelerate” sales. Read more
July 21, 2014 by Arezu Sarvestani
California-based Biolase announced today that it secured $12 million in a private placement funding round, even as the company weathers the internal tumult following the ouster of former CEO Federico Pignatelli.
Biolase raised the funds through commitments from Jack Schuler (of Crabtree Partners), Oracle Partners L.P. and other Oracle funds, Birchview Capital and certain Biolase directors and officers who bought an aggregate of nearly 6.3 million shares at $1.92 apiece, according to a press release. Read more
July 23, 2014 by Brad Perriello
Trice Medical said it raised the 1st tranche of an $11.6 million Series B round and named medtech veteran Jeffrey O’Donnell Sr. as its new CEO.
Trice, which is developing a “micro-invasive” device called Mi-eye for outpatient diagnostic arthroscopy, said the round was led by a nearly $1.3 million contribution from Safeguard Scientifics that’s worth a 9.6% stake. BioStar Ventures and other prior backers also participated, according to a press release. Read more